Your browser doesn't support javascript.
loading
Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes.
Inzucchi, Silvio E; Davies, Melanie J; Khunti, Kamlesh; Trivedi, Prabhav; George, Jyothis T; Zwiener, Isabella; Johansen, Odd Erik; Sattar, Naveed.
Afiliación
  • Inzucchi SE; Yale University School of Medicine, New Haven, Connecticut, USA.
  • Davies MJ; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Khunti K; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Trivedi P; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • George JT; Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Zwiener I; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany.
  • Johansen OE; Boehringer Ingelheim Norway KS, Asker, Norway.
  • Sattar N; Institute of Cardiovascular & Medical Sciences, University of Glasgow, Glasgow, UK.
Diabetes Obes Metab ; 23(2): 425-433, 2021 02.
Article en En | MEDLINE | ID: mdl-33084149
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2021 Tipo del documento: Article